Hexagon Nutrition Ltd (HEXAGON) — shareholding pattern, promoter holding, financials and share price
About Hexagon Nutrition Ltd (HEXAGON)
Hexagon Nutrition Ltd operates in the Pharmaceuticals industry, within the Healthcare sector. It trades on the NSE as HEXAGON and on the BSE under scrip code 544785. Its ISIN is INE0JUI01012.
Incorporated in 1993, Hexagon Nutrition Ltd is a research-driven nutrition company. [1]
Listed peers in Pharmaceuticals: Bharat Parenterals Ltd, Kopran Ltd, Shree Ganesh Remedies Ltd, Remus Pharmaceuticals Ltd, Sigachi Industries Ltd, Anlon Healthcare Ltd.
Valuation & Returns
10 Jul 2026At ₹71.93 a share on 10 Jul 2026, Hexagon Nutrition Ltd (HEXAGON) was valued at a price-to-earnings ratio of 23.43x against an industry P/E of 36.41x and a price-to-book of 3.06x on a book value of ₹23.48 per share. Solomo computes return on equity of 16.26% and return on capital employed of 20.71% from filed results.
- P/E
- 23.43x
- Industry P/E
- 36.41x
- P/B
- 3.06x
- EPS (TTM)
- ₹1.98
- Book value / share
- ₹23.48
- ROE
- 16.26%
- ROCE
- 20.71%
- Debt / equity
- 0.14x
- Dividend yield
- 0%
- 52-week range
- ₹48 – ₹77.47
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, Hexagon Nutrition Ltd (HEXAGON) reported revenue of ₹383 crore, net profit of ₹38 crore and earnings per share of ₹3.43. That compares with revenue of ₹325 crore and net profit of ₹24 crore in Mar 2025. Figures are consolidated, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹115 crore and net profit ₹11 crore (consolidated).
| Metric | Mar 2021 | Mar 2022 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue (₹ cr) | 211 | 271 | 298 | 325 | 383 |
| Net profit (₹ cr) | 23 | 23 | 12 | 24 | 38 |
| EPS (₹) | 2.07 | 2.11 | 1.1 | 2.2 | 3.43 |
| Measure | 5Y | 3Y | 1Y |
|---|---|---|---|
| Sales growth | 2.13% | 14.92% | 9.14% |
| Profit growth | 10.56% | 22.49% | 99.67% |
Ownership Summary
Jun 2026As of Jun 2026, promoters hold 64.29% of Hexagon Nutrition Ltd (HEXAGON), foreign institutional investors (FII) hold 0.29% and domestic institutional investors (DII) hold 6.43%. Market capitalisation was ₹884 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Jun 2026.
Largest disclosed public shareholders in Jun 2026: BANDHAN SMALL CAP FUND 2.44%, VINAY RAJENDRAKUMAR NAGDA 2.44%, AMPERSAND GROWTH OPPORTUNITIES FUND SCHEME- I 1.83%, CP CAPITAL LIMITED 1.74%, ARUN GOEL 1.4%, HUF 1.31%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Jun 2026 | 64.29% | - | 0.29% | 6.43% | 35.71% |